Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kishio Furuya has a total of 141 co-authors. Here are the top co-authors by number of shared publications:

  • Masahiro Sokabe

    Mechanobiology Laboratory, Nagoya University Graduate School of Medicine, Nagoya, Japan

    20 shared publications
  • Shunichi Yamagishi

    National Institute for Physiological Sciences, Okazaki, 444-8585

    16 shared publications
  • Masahiro Sokabe

    Nagoya University Graduate School of Medicine

    8 shared publications
  • Sonoko Furuya

    Section of Brain Structure, Center for Brain Experiment, National Institute for Physiological Sciences, Okazaki 444-8585, Japan

    8 shared publications
  • Toshikazu Kiyohara

    Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Kyoto, Japan

    7 shared publications
  • Yoshinori Hasegawa

    Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

    6 shared publications

Latest Publications

  • Open Access

    Volume-regulated anion channels conduct ATP in undifferentiated mammary cells and promote tumorigenesis in xenograft nude mouse

    by Kishio Furuya, Hiroaki Hirata, Takeshi Kobayashi, Hiroshi Ishiguro, Masahiro Sokabe

    The high interstitial ATP concentration in the cancer microenvironment is a major source of adenosine, which acts as a strong immune suppressor. However, the source of ATP release has not been elucidated. We measured ATP release during hypotonic stress using a real-time ATP luminescence imaging system in breast cell lines and in primary cultured mammary cells. In breast cell lines, ATP was released with a slowly rising diffuse pattern, whereas in primary cultured cells, ATP was intermittently released with transient-sharp peaks. The diffuse ATP release pattern changed to a transient-sharp pattern by cholera toxin treatment and the reverse change was induced by transforming growth factor (TGF) β treatment. DCPIB, an inhibitor of volume-regulated anion channels (VRACs), suppressed the diffuse pattern. The inflammatory mediator sphingosine-1-phosphate (S1P) induced a diffuse ATP release pattern isovolumetrically. Knockdown of the A isoform of leucine-rich repeat-containing protein 8 (LRRC8A), the essential molecular entity of VRACs, using shRNA suppressed the diffuse pattern. In the nude mouse xenograft model, LRRC8A knockdown suppressed the tumorigenesis of subcutaneously implanted breast cancer cells. These results suggest that abundantly expressed VRACs are a conduit of ATP release in undifferentiated cells, including cancer cells.


  • Open Access

    Sphingosine-1-Phosphate Induces ATP Release via Volume-Regulated Anion Channels in Breast Cell Lines

    by Kishio Furuya, Hiroaki Hirata, Takeshi Kobayashi, Masahiro Sokabe

    High interstitial level of ATP and its lysate adenosine in the cancer microenvironment are considered a halo mark of cancer. Adenosine acts as a strong immune suppressor. However, the source of ATP release is unclear. We clarified the release of ATP via volume-regulated anion channels (VRACs) in breast cell lines using an ATP luminescence imaging system. We detected a slowly rising diffuse pattern of ATP release that was only observed in undifferentiated cells, not in differentiated primary cultured cells. This was confirmed by suppression with DCPIB, a blocker of VRACs, and shRNA for LRRC8A, an indispensable subunit of VRACs. We herein demonstrated that the inflammatory mediator sphingosine-1-phosphate (S1P), which exists abundantly in the cancer microenvironment, induced a diffuse pattern of ATP release isovolumetrically. The response was dose-dependent and suppressed by the knock-down of LRRC8A. It was also suppressed by blockers of S1P receptor 1 and 2 (W146 and JTE013, respectively). RTqPCR demonstrated the prominent presence of S1PR1 and S1PR2 mRNAs. We discussed the roles of S1P-induced ATP release in the cancer microenvironment.


  • Open Access

    Lytic Release of Cellular ATP: Physiological Relevance and Therapeutic Applications

    by Ryszard Grygorczyk, Francis Boudreault, Olga Ponomarchuk, Ju Jing Tan, Kishio Furuya, Joseph Goldgewicht, Falonne Démèze Kenfack, François Yu

    The lytic release of ATP due to cell and tissue injury constitutes an important source of extracellular nucleotides and may have physiological and pathophysiological roles by triggering purinergic signalling pathways. In the lungs, extracellular ATP can have protective effects by stimulating surfactant and mucus secretion. However, excessive extracellular ATP levels, such as observed in ventilator-induced lung injury, act as a danger-associated signal that activates NLRP3 inflammasome contributing to lung damage. Here, we discuss examples of lytic release that we have identified in our studies using real-time luciferin-luciferase luminescence imaging of extracellular ATP. In alveolar A549 cells, hypotonic shock-induced ATP release shows rapid lytic and slow-rising non-lytic components. Lytic release originates from the lysis of single fragile cells that could be seen as distinct spikes of ATP-dependent luminescence, but under physiological conditions, its contribution is minimal <1% of total release. By contrast, ATP release from red blood cells results primarily from hemolysis, a physiological mechanism contributing to the regulation of local blood flow in response to tissue hypoxia, mechanical stimulation and temperature changes. Lytic release of cellular ATP may have therapeutic applications, as exemplified by the use of ultrasound and microbubble-stimulated release for enhancing cancer immunotherapy in vivo.


  • Open Access

    Hypo-osmotic Stress Induces ATP Release via Volume-regulated Anion Channels in Undifferentiated Mammary Cells

    by Kishio Furuya, Yuko Takahashi, Hiroaki Hirata, Takeshi Kobayashi, Mikhail Samsonov, Masahiro Sokabe

    The high interstitial ATP concentration in the cancer microenvironment is a major source of adenosine, which acts as a strong immune suppressor. However, the source of ATP release has not been elucidated. We measured the ATP release during hypotonic stress using a real-time ATP luminescence imaging system in primary cultured mammary cells and in breast cell lines. In primary cultured cells, ATP was intermittently released with transient-sharp peaks, while in breast cell lines ATP was released with a slowly rising diffuse pattern. The diffuse ATP release pattern was changed to a transient-sharp pattern by cholera toxin treatment and the reverse change was induced by transforming growth factor (TGF) β treatment. DCPIB, an inhibitor of volume-regulated anion channels (VRACs), only suppressed the diffuse pattern. The inflammatory mediator sphingosine-1-phosphate (S1P) induced a diffuse ATP release pattern isovolumetrically. The knockdown of A isoform of leucine-rich repeat-containing protein 8 (LRRC8A), the essential molecular entity of VRACs, using shRNA suppressed the diffuse pattern. These results suggest that abundantly expressed VRACs are a conduit of ATP release in undifferentiated cells, including cancer cells. Summary statement ATP release via volume-regulated anion channels (VRACs) was confirmed in breast cell lines using an ATP imaging system. Its contribution to ATP abundance in the cancer microenvironment was discussed.


  • Mechanosensitive ATP release in the lungs: New insights from real-time luminescence imaging studies

    by Ryszard Grygorczyk, Francis Boudreault, Ju Jing Tan, Olga Ponomarchuk, Masahiro Sokabe, Kishio Furuya


  • Open Access

    Cyclic stretch enhances reorientation and differentiation of 3-D culture model of human airway smooth muscle

    by Shuichi Asano, Satoru Ito, Mika Morosawa, Kishio Furuya, Keiji Naruse, Masahiro Sokabe, Etsuro Yamaguchi, Yoshinori Hasegawa


  • Real-time imaging of mechanically and chemically induced ATP release in human lung fibroblasts

    by Kota Takahashi, Satoru Ito, Kishio Furuya, Shuichi Asano, Masahiro Sokabe, Yoshinori Hasegawa


  • Neurosteroid dehydroepiandrosterone enhances activity and trafficking of astrocytic GLT‐1viaσ1receptor‐mediated PKC activation in the hippocampal dentate gyrus of rats

    by Tingting Chen, Motoki Tanaka, Ya Wang, Sha Sha, Kishio Furuya, Ling Chen, Masahiro Sokabe

    Neurosteroid dehydroepiandrosterone (DHEA) has been reported to exert a potent neuroprotective effect against glutamate‐induced excitotoxicity. However, the underlying mechanism remains to be elucidated. One of the possible mechanisms may be an involvement of astrocytic glutamate transporter subtype‐1 (GLT‐1) that can quickly clear spilled glutamate at the synapse to prevent excitotoxicity. To examine the effect of DHEA on GLT‐1 activity, we measured synaptically induced glial depolarization (SIGD) in the dentate gyrus (DG) of adult rats by applying an optical recording technique to the hippocampal slices stained with voltage‐sensitive dye RH155. Bath‐application of DHEA for 10 min dose‐dependently increased SIGD without changing presynaptic glutamate releases, which was sensitive to the GLT‐1 blocker DHK. Patch‐clamp recordings in astrocytes showed that an application of 50 μM DHEA increased glutamate‐evoked inward currents (Iglu) by approximately 1.5‐fold, which was dependent on the GLT‐1 activity. In addition, the level of biotinylated GLT‐1 protein in the surface of astrocytes was significantly elevated by DHEA. The DHEA‐increased SIGD,Iglu, and GLT‐1 translocation to the cell surface were blocked by the σ1R antagonist NE100 and mimicked by the σ1R agonist PRE084. DHEA elevated the phosphorylation level of PKC in a σ1R‐dependent manner. Furthermore, the PKC inhibitor chelerythrine could prevent the DHEA‐increased SIGD,Iglu, and GLT‐1 translocation. Collectively, present results suggest that DHEA enhances the activity and translocation to cell surface of astrocytic GLT‐1 mainlyviaσ1R‐mediated PKC cascade.


  • Open Access

    Matrix stiffness regulates migration of human lung fibroblasts

    by Shuichi Asano, Satoru Ito, Kota Takahashi, Kishio Furuya, Masashi Kondo, Masahiro Sokabe, Yoshinori Hasegawa

    In patients with pulmonary diseases such as idiopathic pulmonary fibrosis and severe acute respiratory distress syndrome, progressive pulmonary fibrosis is caused by dysregulated wound healing via activation of fibroblasts after lung inflammation or severe damage. Migration of fibroblasts toward the fibrotic lesions plays an important role in pulmonary fibrosis. Fibrotic tissue in the lung is much stiffer than normal lung tissue. Emerging evidence supports the hypothesis that the stiffness of the matrix is not only a consequence of fibrosis, but also can induce fibroblast activation. Nevertheless, the effects of substrate rigidity on migration of lung fibroblasts have not been fully elucidated. We evaluated the effects of substrate stiffness on the morphology, α‐smooth muscle actin (α‐SMA) expression, and cell migration of primary human lung fibroblasts by using polyacrylamide hydrogels with stiffnesses ranging from 1 to 50 kPa. Cell motility was assessed by platelet‐derived growth factor (PDGF)‐induced chemotaxis and random walk migration assays. As the stiffness of substrates increased, fibroblasts became spindle‐shaped and spread. Expression of α‐SMA proteins was higher on the stiffer substrates (25 kPa gel and plastic dishes) than on the soft 2 kPa gel. Both PDGF‐induced chemotaxis and random walk migration of fibroblasts precultured on stiff substrates (25 kPa gel and plastic dishes) were significantly higher than those of cells precultured on 2 kPa gel. Transfection of the fibroblasts with short interfering RNA for α‐SMA inhibited cell migration. These findings suggest that fibroblast activation induced by a stiff matrix is involved in mechanisms of the pathophysiology of pulmonary fibrosis.


  • Open Access

    Hyperforin/HP-β-Cyclodextrin Enhances Mechanosensitive Ca2+ Signaling in HaCaT Keratinocytes and in Atopic Skin Ex Vivo Which Accelerates Wound Healing

    by Hiroya Takada, Jun Yonekawa, Masami Matsumoto, Kishio Furuya, Masahiro Sokabe

    Cutaneous wound healing is accelerated by mechanical stretching, and treatment with hyperforin, a major component of a traditional herbal medicine and a known TRPC6 activator, further enhances the acceleration. We recently revealed that this was due to the enhancement of ATP-Ca2+ signaling in keratinocytes by hyperforin treatment. However, the low aqueous solubility and easy photodegradation impede the topical application of hyperforin for therapeutic purposes. We designed a compound hydroxypropyl-β-cyclodextrin- (HP-β-CD-) tetracapped hyperforin, which had increased aqueous solubility and improved photoprotection. We assessed the physiological effects of hyperforin/HP-β-CD on wound healing in HaCaT keratinocytes using live imaging to observe the ATP release and the intracellular Ca2+ increase. In response to stretching (20%), ATP was released only from the foremost cells at the wound edge; it then diffused to the cells behind the wound edge and activated the P2Y receptors, which caused propagating Ca2+ waves via TRPC6. This process might facilitate wound closure, because the Ca2+ response and wound healing were inhibited in parallel by various inhibitors of ATP-Ca2+ signaling. We also applied hyperforin/HP-β-CD on an ex vivo skin model of atopic dermatitis and found that hyperforin/HP-β-CD treatment for 24 h improved the stretch-induced Ca2+ responses and oscillations which failed in atopic skin.